MIL •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/11/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeMIL
Market Capitalization144,345 mln
Float1,239 mln
Earnings Date05/07/2026
EPS
6.31
Strong
P / E
16.65
Moderately valued
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.36
Borderline
Relative Strength
17
/ 100
Significantly lagging
Debt / Equity
1.10
Elevated leverage
Business Description
Gilead Sciences is an American company founded in 1987 and based in Foster City, California, that researches and sells treatments for serious diseases with few existing options. Its portfolio covers HIV, hepatitis B and C, certain cancers, fungal infections, and COVID-19, with products sold across the United States, Europe, and other markets worldwide. The company works alongside a range of partners to discover and develop new therapies, including cancer-targeting antibodies and small molecule treatments.
